XML 94 R80.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Aug. 31, 2022
May 25, 2022
Oct. 20, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity (Details) [Line Items]            
Proceeds from issuance     $ 108,737      
Net of issuance expenses     $ 509      
Weighted average grant date fair values of options granted (in Dollars per share)       $ 7.22 $ 10.35 $ 7.99
Total intrinsic value of options exercised       $ 250 $ 8,505 $ 11,658
Total equity-based compensation expenses       3,835 $ 4,711 $ 3,987
Compensation costs related to RSUs       794    
Total unrecognized compensation cost       $ 8,329    
Weighted-average period       1 year 10 months 2 days    
2011 Plan [Member]            
Equity (Details) [Line Items]            
Exercised period       6 years    
Total number of common shares available (in Shares)       8,000,000    
Adoption plan term       10 years    
2021 Plan [Member]            
Equity (Details) [Line Items]            
Common shares available for future grant (in Shares)       1,560,205    
IPO [Member]            
Equity (Details) [Line Items]            
Shares issued (in Shares)     3,898,304      
Shares issued price per share (in Dollars per share)     $ 29.5      
Board of directors [Member]            
Equity (Details) [Line Items]            
Common share price (in Dollars per share) $ 0.23 $ 0.47        
Common share total amount $ 12,679 $ 25,900